All News #Library
Others
NervGen Pharma Reveals 2025 Financials And Business Updates
31 Mar 2026 //
GLOBENEWSWIRE
NervGen Names Ruff Chief Regulatory Affairs Officer, McSherry SVP
04 Mar 2026 //
GLOBENEWSWIRE
NervGen Announces Retirement of CFO, Bill Adams
12 Feb 2026 //
GLOBENEWSWIRE
Nervgen Pharma Names Adam Rogers Ceo For Spinal Cord Injury
09 Feb 2026 //
GLOBENEWSWIRE
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22
20 Jan 2026 //
GLOBENEWSWIRE
NervGen Pharma Begins Trading On Nasdaq Today
08 Jan 2026 //
GLOBENEWSWIRE

Market Place
Sourcing Support